da Costa, J.J.; Christ, L.; Villiger, P.M.; Vogel, M.; Bachmann, M.F.
Anti-IL-6 Receptor Treatment in Giant Cell Arteritis Patients Reduces Levels of IL-1β-Receptor Antagonist but Not IL-1β. Rheumato 2024, 4, 63-74.
https://doi.org/10.3390/rheumato4020006
AMA Style
da Costa JJ, Christ L, Villiger PM, Vogel M, Bachmann MF.
Anti-IL-6 Receptor Treatment in Giant Cell Arteritis Patients Reduces Levels of IL-1β-Receptor Antagonist but Not IL-1β. Rheumato. 2024; 4(2):63-74.
https://doi.org/10.3390/rheumato4020006
Chicago/Turabian Style
da Costa, Joana J., Lisa Christ, Peter M. Villiger, Monique Vogel, and Martin F. Bachmann.
2024. "Anti-IL-6 Receptor Treatment in Giant Cell Arteritis Patients Reduces Levels of IL-1β-Receptor Antagonist but Not IL-1β" Rheumato 4, no. 2: 63-74.
https://doi.org/10.3390/rheumato4020006
APA Style
da Costa, J. J., Christ, L., Villiger, P. M., Vogel, M., & Bachmann, M. F.
(2024). Anti-IL-6 Receptor Treatment in Giant Cell Arteritis Patients Reduces Levels of IL-1β-Receptor Antagonist but Not IL-1β. Rheumato, 4(2), 63-74.
https://doi.org/10.3390/rheumato4020006